Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Conformal radiotherapy patch and manufacturing method and application thereof

A manufacturing method and conformal technology, applied in the fields of medical treatment and beauty, can solve the problems of long half-life of nuclide, tedious and long treatment cycle, environmental pollution, etc.

Active Publication Date: 2017-05-31
CHENGDU WEINING BIOLOGICAL TECH +1
View PDF16 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0022] The problems of these two kinds of applicators in the prior art are: one, the nuclide half-life is long, the risk of contamination is large, 90 The half-life of Sr is 28 years, and if it leaks, it will cause great pollution to the environment; second, it can only be used in hospitals, and patients' compliance is poor. 90 Sr / 90 Y and 32 Each course of P application requires 8-10 treatments, and many intractable diseases require 2-3 courses of treatment to be effective. Such a cumbersome and long treatment cycle makes most patients unable to persist; third, the radioactive dose cannot be counted, and doctors only Able to estimate time based on experience

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Conformal radiotherapy patch and manufacturing method and application thereof
  • Conformal radiotherapy patch and manufacturing method and application thereof
  • Conformal radiotherapy patch and manufacturing method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0084] Disease Type: Skin Hemangioma

[0085] There were 83 cases of skin hemangioma, including 59 cases of simple capillary hemangioma, accounting for 72%; 7 cases of cavernous hemangioma, accounting for 8%; 17 cases of port wine stain and mixed hemangioma, accounting for 20%. There were 62 cases of round and oval lesions, and 21 cases of abnormal shape. According to the patient's condition and the radioactive dose calculation system, the nuclide of the conformal radiotherapy patch is P-32, the activity range is 0.37-200 MBq, and the material of the support is high-quality filter paper with an area of ​​0.1-50 cm 2 , the thickness is 0.1-2 mm, and the protection adopts lead rubber with a thickness of 0.1-2 mm. The warning device is common for sound warning and light warning.

[0086] The total radiation dose of the patients was 15-55 Gy. According to the changes of the condition, a total of 20 cases (25%) were treated again after 3-4 weeks.

[0087] Treatment effect: 75 cas...

Embodiment 2

[0089] Disease type: Keloid

[0090] There were 126 cases of keloids, 102 cases of lesions were round and oval, 10 cases were approximately square, and 14 cases were abnormal. According to the calculation of the patient's condition and the radioactive dose calculation system, the nuclide of the conformal radiotherapy patch is Y-90, the activity range is 10-600 MBq, and the material of the support is a water-absorbing resin film with an area of ​​1-180 cm 2 , the thickness is 0.1-3mm, the protection adopts copper-containing rubber with a thickness of 0.1-3mm, and the warning device is common for sound warning and vibration warning.

[0091] The total irradiation dose for patients is 30-100 Gy, and the cure rate of keloid is low in one treatment, and about 30% of patients need 2-4 treatments.

[0092] Treatment effect: 95 cases were cured, accounting for 76%; 21 cases were significantly improved, accounting for 17%; 11 cases were improved, accounting for 9%, the total effective...

Embodiment 3

[0094] Disease Type: Neurodermatitis

[0095] There were 289 cases of neurodermatitis, and 289 cases had round and oval lesions. According to the calculation of the patient's condition and the radioactive dose calculation system, the nuclide of the conformal radiotherapy patch is Re-188, the activity range is 30-740 MBq, the material of the support is high molecular polymer, and the area is 1-180 cm 2 , the thickness is 1-5 mm, the protection is made of aluminum rubber with a thickness of 1-5 mm, and the warning device is common for sound warning and light warning.

[0096] The total dose of radiation therapy for patients is 20-40 Gy.

[0097] Treatment effect: After 1-3 courses of treatment, the cure rate is 82%, the effective rate is 98%, and the recurrence rate is 12%. After the recurrence, the patient needs to undergo 1-3 courses of treatment again.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Areaaaaaaaaaaa
Thicknessaaaaaaaaaa
Areaaaaaaaaaaa
Login to View More

Abstract

The invention relates to a conformal radiotherapy patch and a manufacturing method and application thereof. The conformal radiotherapy patch comprises a seal film, a support part, a protective material and a dosage monitoring and controlling device, wherein the support part is used for immobilizing radionuclides. The conformal radiotherapy patch is characterized in that the support part which immobilizes the radionuclides is sealed by the seal film and the protective material, the dosage monitoring and controlling device monitors and controls dosage of the radionuclides through pores of the protective material, a half-life period of the radionuclides is shorter than four days, and pure beta rays are adopted. Therefore, high compliance and conformality and short half-life period of the radionuclides are realized, continuous radiotherapy and precise monitoring and controlling are both achieved, and defects of existing radiopharmaceuticals in targeted continuous treatment and dosage control precision in treatment of skin diseases are improved.

Description

technical field [0001] The invention belongs to the field of medical treatment and cosmetology, and relates to a novel external radiotherapy product, which is mainly composed of radionuclides and related auxiliary equipment. In further detail, it relates to a conformal radiotherapy plaster for treating various skin diseases and superficial tumors, its manufacturing method and application. Background technique [0002] Cutaneous hemangioma is a benign skin vascular lesion caused by congenital vascular dysplasia. It is the most common benign tumor in infants and young children. The incidence rate is 1%-2% in newborns, and as high as 12% after 1 year old. Hemangiomas were divided into four types: simple capillary hemangioma (strawberry hemangioma), port wine stain, cavernous hemangioma, and mixed hemangioma. It usually grows rapidly within 1 year, especially within half a year, and some can gradually degenerate within 5-7 years. However, some hemangiomas will not regress on t...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61M36/14A61K51/12A61P17/02A61P35/00A61K103/00
CPCA61K51/1279A61N5/1029A61N5/1048A61N2005/1092A61N2005/1094
Inventor 王铖锴韩东乔石峰
Owner CHENGDU WEINING BIOLOGICAL TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com